![Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer - Annals of Oncology Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c455686a-e48e-4e3a-9d2f-d4213f57539c/gr1_lrg.jpg)
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer - Annals of Oncology
![Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer - Annals of Oncology Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cda5c647-4f45-45c1-b3c6-2c291cf2913d/gr2b_lrg.jpg)
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer - Annals of Oncology
![Lokální terapie v paliativní onkologii - 28. 3. 2013, Institut onkologie a rehabilitace Na Pleši » Linkos.cz Lokální terapie v paliativní onkologii - 28. 3. 2013, Institut onkologie a rehabilitace Na Pleši » Linkos.cz](https://www.linkos.cz/files/akce/2013/Ples-logo.jpg)